Verve Ventures
VC Fund
Zug, Switzerland
Verve Ventures is a European startup investment platform for qualified and institutional investors. Their fully digital platform enables private investors to build a diversified portfolio with investments starting at CHF/EUR 10'000. Since its launch in 2010, Verve Ventures has invested more than EUR 130 million in over 100 startups. Their community consists of 5’000 registered qualified private investors, family offices, and pension funds. Several institutional investors such as a large Swiss pension fund and numerous corporates also rely on their expertise to invest in promising startups. Verve Ventures is backed by Switzerland's third-largest bank, Zürcher Kantonalbank. They have a dedicated investment team based in Zurich, Lausanne, Berlin, Paris, and Cambridge, that screens thousands of startups each year and selects the top 1% after a rigorous due diligence process. They are reshaping the European venture capital landscape and granting investors superior access to this traditionally intransparent asset class. They source the best deals, and structure rounds, and enable their investors to participate in competitive startup deals.
- Total investments:
- 305
- Last investment:
- Lead investor:
- 14%
- Fund size:
- $61M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Verve Ventures invests in
Stages Verve Ventures invests in
Countries Verve Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 15 contacts → | |||
Round size
- Seed
- $1.2M–$12M
- Series A
- $2.1M–$18M
- Series B
- $3.9M–$45M
Investment Focus
Industry
- Software 44 (14%)
- Health Care 39 (13%)
- Biotechnology 26 (9%)
- Artificial Intelligence 25 (8%)
- Information Technology 24 (8%)
Stage
- Seed 78 (26%)
- Series A 77 (25%)
- Series B 40 (13%)
- Venture - Series Unknown 19 (6%)
- Series C 15 (5%)
Country
- Switzerland 98 (32%)
- Germany 24 (8%)
- France 19 (6%)
- United Kingdom 18 (6%)
- United States 4 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexander Seel
Institutional clients
|
Institutional clients | Total investments: 0 | Find email | |
Chris Gay-Crosier
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
Chris Gay-Crosier
Investment Manager
|
Investment Manager | Total investments: 2 | Find email | |
Lukas Weber
Co-Founder, Co-Chief Executive Officer & Chairman
|
Co-Founder, Co-Chief Executive Officer & Chairman | Total investments: 3 | Find email | |
Michael Blank
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs. | $18M / Seed / Oct 12, 2026 | ||
| There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg andfoot ulcers.The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life. The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.By developing a therapy which is safe and effective we hope to set a better future for patients in need. | $25M / Venture - Series Unknown / Sep 17, 2026 | ||
| Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes. | $5.1M / Pre-Seed / Jul 06, 2026 | ||
| Atana is a data-driven resource company that accelerates the exploration and development of flowing critical minerals. | $27.5M / Seed / Jun 02, 2026 | ||
| Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies. | $250M / Series C / Feb 24, 2026 | ||
| Haelixa provides IN-product traceability solutions to ensure consumer's good supply chain transparency and integrity. | $2.4M / Seed / Feb 03, 2026 | ||
| NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit | $18.5M / Seed / Nov 20, 2025 | ||
| FMC is the provider of extremely efficient FeFET memory solutions for non-volatile storage. FeFET is ultra-low-power, high-performance, very dense, and extremely temperature stable. It will scale to transistor sizes ranging from 28nm to 5nm and below. The FMC team has been supported by “EXIST Forschungstransfer”, a program of the Federal Ministryfor Economic Affairs and Energy. The company is based in Dresden, Germany.FMC commercializes a disruptive material innovation that will solve this problem for current and future technology nodes, i.e. eNVM based on ferroelectric hafnium oxide (FE-HfO2). The unexpected physical effect of ferroelectricity in HfO2 allows for the transformation of classical high-k metal-gate (HKMG) transistors into nonvolatile ferroelectric field effect transistors (FeFET). In this way, MCUs can easily be scaled from e.g. 65 nm down to 28 nm and beyond enabling tremendous advantages for the overall system: SoC cost reduction of around 80%, per bit write energy reduction by a factor of 1000 and an overall performance gain of the system of around 70% due to the transition to advanced process nodes. Due to the close relation of FeFET and CMOS baseline, there is no roadblock for FMC’s technology to be applied to cutting-edge technology nodes like 22 nm FDSOI, 1X nm FinFET and beyond. | $89.6M / Series C / Nov 13, 2025 | ||
| Our breakthrough sustainable aviation fuel (SAF) technology, aerobrew™, will make affordable net-zero aviation a reality. The technology is innovative, highly scaleable and able to tap into future global renewable energy systems efficiently. Starting from renewable feedstocks including green hydrogen, driven by renewable electricity, andsustainably sourced CO2, for example from direct air capture, aerobrew™ provides an efficient route to large-scale production of e-kerosene, overcoming the scale up challenges and high costs of alternative e-fuels technologies. aerobrew™ is also compatible with the biogenic route whereby the carbon required for the process is derived from renewable and sustainable cellulosic biomass which, does not compete with the food chain (wood, miscanthus, etc.). With a high carbon conversion, high selectivity and a high overall SAF yield, aerobrew™ leads to attractive production economics and cost leadership. With a rapidly growing demand for SAF, aerobrew™ stands to contribute significantly to the decarbonisation of global aviation and to support the achievement of net zero 2050 targets. | $24.8M / Series A / Nov 06, 2025 | ||
| Sizable Energy addresses the critical need for secure, affordable, and sustainable energy storage. Sizable Energy patented technology and straightforward design extends pumped hydro deployment to any offshore location with a depth of at least a few hundred meters. By leveraging a novel, modular, and easily deployable method, we utilize thegravitational potential of a solution 20% heavier than seawater, like saturated sea salt brine, within seawater. | $8.8M / Seed / Oct 22, 2025 | ||
| See all 305 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Verve Ventures invest in?
Verve Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 305 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Verve Ventures invest in?
Verve Ventures typically joins rounds of $1.2M–$12M at Seed, $2.1M–$18M at Series A and $3.9M–$45M at Series B. These are whole funding-round sizes, not Verve Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Verve Ventures took part in.
How do I contact Verve Ventures?
Public channels for Verve Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Verve Ventures?
The team at Verve Ventures includes Alexander Seel (Institutional clients), Chris Gay-Crosier (Investment Manager) and Chris Gay-Crosier (Investment Manager), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
